Patents
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
08/2008
08/20/2008CN101248041A 鞘氨醇激酶抑制剂 Sphingosine kinase inhibitors
08/20/2008CN101245041A Process for producing 4,4'-bis(2,4-diaminophenyloxy)diphenyl sulfone
08/20/2008CN100412057C Process for preparing sulindac
08/19/2008US7414139 Catalytic antioxidants and methods of use
08/19/2008CA2310714C Process for preparing neuraminidase inhibitor ro-64-0796
08/14/2008WO2008041140A3 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
08/14/2008US20080194880 Process For the Preparation of Polymorphs of Mesotrione
08/14/2008US20080194651 Nitroderivatives as drugs for diseases having an inflammatory basis
08/13/2008EP1954652A2 An improved process for the preparation of armodafinil
08/13/2008EP1620394B1 Method for crystallizing guanidinium salts
08/13/2008EP1431283B1 Process for producing mixture of dihydroxydiphenylsulfone isomers
08/13/2008CN101243040A Process for the synthesis of mandipropamid and derivatives thereof
08/13/2008CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
08/13/2008CN100409844C Noval compound, its synthetizing process and therapeutic use
08/12/2008US7411088 Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7411004 Sulphones which modulate the action of gamma secretase
08/07/2008WO2008093711A1 Solid-phase oxidation reaction system
08/07/2008WO2008093506A1 Recording material composition comprising crosslinked diphenylsulfone compound
08/07/2008US20080188654 Compounds for treatment of inflammation, diabetes and related disorders
08/07/2008US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/06/2008EP1953138A2 Fenicol compounds and methods of synthesizing 2-trifluoracetamido-3-substituted propiophenone compounds
08/06/2008EP1951664A1 Organic sulfur compounds and use thereof as arthropodicides
08/06/2008EP1951217A2 Chemical compounds
08/06/2008EP1592388A4 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin
08/06/2008CN101238370A Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin
08/06/2008CN101235005A Method for preparing 4,4'-di(2,4-dinitorphenoxy)-3,3',5,5'-tetramethyldiphenyl sulphone
08/06/2008CN100408539C Vitamin d receptor modulators
08/05/2008US7408008 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
08/05/2008US7407990 Therapeutic Agents
08/05/2008CA2392903C Trans olefinic glucokinase activators
07/2008
07/31/2008US20080182968 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
07/30/2008EP1948594A1 Process for the synthesis of intermediates of chloramphenicol or its analogues
07/30/2008EP1603918B1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
07/30/2008EP1059927B1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity
07/30/2008CN101230026A Method for preparing 4,4'-di(2,4-dinitro-phenoxy) sulfone
07/30/2008CN100406524C Sulfoxider or sulfones gralted onto polymers
07/29/2008US7405323 Invention provides five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing; sleep disorders
07/29/2008CA2218702C Fatty acid esters as bioactive compounds
07/29/2008CA2168192C 4-aminobenzoylguanidine derivatives
07/24/2008US20080176852 Biguanide and dihydrotriazine derivatives
07/24/2008US20080176255 Mold detection composition and methods
07/23/2008EP1945608A1 Synthesis of methylsulphonyl benzene compounds
07/23/2008CN101228116A Benzoyl-substituted serineamides
07/23/2008CN100404503C Monomer compound, graft copolymer compound, production method thereof, polymer electrolyte membrane, and fuel cell
07/23/2008CN100404502C Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
07/22/2008US7402704 Arylsulfones and uses related thereto
07/22/2008CA2481246C Compounds that modulate ppar activity and methods for their preparation
07/17/2008US20080171896 Process for Enantioselective Synthesis of Single Enantiomers of Modafinil by Asymmetric Oxidation
07/16/2008CN100402496C Compounds useful as matrix metalloprotease inhibitors
07/16/2008CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia
07/15/2008US7399878 Pharmaceutical compounds
07/15/2008US7399775 β-amyloid protein production/secretion inhibitor
07/15/2008US7399577 Halogenated oxime derivatives and the use thereof
07/15/2008CA2371283C Process and apparatus for making ultra-pure dmso
07/10/2008US20080167474 Effective agents for trapping and indentifying free radical species and find use as efficient antioxidants in physicochemical and biological systems; treatment or prevention of oxidative, ischemic, ischemia/reperfusion-related and chemokine-mediated conditions
07/09/2008EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
07/09/2008EP1465863B1 Potassium channel modulators
07/09/2008EP1379496B1 Sulphones which modulate the action of gamma secretase
07/09/2008CN100400507C Modafinil synthesis process
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/08/2008CA2438009C Novel aromatic sulfonic acid ester derivative, polyarylene, polyarylene having sulfonic acid group and process for producing the same, and polymer solid electrolyte and proton-conductive membrane
07/08/2008CA2376848C Halogenated aromatic compound, polymer thereof, and proton-conductive membrane comprising same
07/03/2008WO2008078811A1 Herbicide containing benzoylpyrazole compound
07/03/2008WO2008078674A1 Glucokinase-activating substance
07/03/2008US20080161612 Chemical intermediates; 1,1,2,3,3,4-hexafluoro-(4-sulfonylalkyl or 4-sulfonylaryl)-1,6-heptadiene derivatives; cationic exchange resins; mechanical properties; electrolytic and fuel cells, lithium batteries; fluoropolymers
07/03/2008US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008CA2672088A1 Glucokinase activator
07/02/2008EP1937634A1 Cathepsin cysteine protease inhibitors
07/02/2008EP1937633A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
07/02/2008EP1937632A1 Novel compounds
07/02/2008EP1937629A2 Benzoylurea compounds and use thereof
07/02/2008CN101209974A Hydroxamic acids derivatives and use thereof
06/2008
06/26/2008WO2008076256A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
06/26/2008WO2008075672A1 Method for producing tris(perfluoroalkanesulfonyl)methide acid salt
06/26/2008WO2008074132A1 Inhibitors of histone deacetylase and prodrugs thereof
06/26/2008WO2007103221A3 An improved process for the preparation of armodafinil
06/26/2008US20080153918 treatment of sleep disorders and related diseases, with five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing
06/26/2008US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy
06/26/2008US20080149888 hydrogenated ionic compound; ammonium, phosphonium, or sulfonium cations; greater environmental compatibility and substantial safety advantages
06/26/2008US20080149878 Fluorosurfactants
06/26/2008CA2672795A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
06/26/2008CA2672192A1 Inhibitors of histone deacetylase and prodrugs thereof
06/25/2008EP1935874A1 S1p3 receptor antagonist
06/25/2008EP1935869A1 Retinoids for the treatment of emphysema
06/25/2008EP1934278A2 Non-staining antidegradants for vulcanized elastomers
06/25/2008CN101208299A Diarylsulfone sulfonamides and use therof
06/24/2008US7390916 Photoprotective cosmetic compositions containing aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile and novel aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile
06/24/2008US7390835 Aralkyl amines as cannabinoid receptor modulators
06/19/2008WO2007069020A3 N-hydroxyamide derivatives possessing antibacterial activity
06/19/2008US20080146849 Synthesis of Ionic Liquids
06/19/2008US20080146632 Fc Receptor Modulating Compounds and Compositions
06/19/2008US20080146527 Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof
06/18/2008EP1931706A1 Collagen receptor i-domain binding modulators
06/18/2008EP1585521B1 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
06/18/2008CN101203485A Amide derivative, pesticide containing such compound and use thereof
06/18/2008CN101200441A Preparation of thiamphenicol
06/17/2008US7388031 Reacting an epoxy compound with a aminocylcohexane-phenyl derivative; useful as anti-obesity, anti-diabetic, cicatrizing and tocolytic medicinal products
06/17/2008CA2284468C Anti-inflammatory compounds
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 159